Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q4 2025 Earnings

Nov 14Confirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.15

0.19

0.54

0.88

Details

Expected EPS

-0.13

Actual EPS

-0.13

Surprise EPS

0

Surprise Percent

+0%

Description

⁨Inhibikase Therapeutics⁩ (⁦IKT⁩) has reported earnings of ⁦-0.13⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.